Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Stefano Omboni, Claudio Borghi, Ambrosioni, Cicero, Stefano Bacchelli, Daniela Degli Esposti, Novo, Dragos Vinereanu, Giuseppe Ambrosio, Reggiardo, Zava
  • ClinicoEconomics and Outcomes Research, July 2013, Taylor & Francis
  • DOI: 10.2147/ceor.s43138

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Stefano Omboni, Dr Arrigo FG CICERO, and Professor Giuseppe Ambrosio